Watch this video to hear about TruSight™ Oncology 500 (TSO500), our solution to enable comprehensive genomic profiling. Get pan-cancer coverage targeting 523 genes from this comprehensive next-generation sequencing (NGS) assay that measures both tumor mutational burden (TMB) and microsatellite instability (MSI) from the same FFPE tumor sample. Recorded at ESMO Immuno-Oncology Congress satellite symposium with the following expert speaker panel: Speakers: • Solange Peters (CHUV, Lausanne, Switzerland) • Andrew Beggs (University of Birmingham, United Kingdom) • Fabrice Magnino (Illumina, EMEA) To get further details on enabling comprehensive genomic profiling, visit our website: https://emea.illumina.com/destination/trusight-oncology-500.html For Research Use Only. Not for use in diagnostic procedures. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM